Bristol Myers Squibb is closing a gene-therapy manufacturing facility in Libertyville that employs 133 workers. It's the second time the facility has been on the losing end of a consolidation play.

To enhance manufacturing capacity as part of an effort to control complex supply chains and align with U.S. R&D activities.

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

More than 500 New Jersey workers are losing their jobs as part of a large-scale restructuring. Here's what we know about the ...

Bristol Myers Squibb plans to cut 516 jobs in NJ as part of a $2B cost-saving initiative, bringing total layoffs this year to ...

Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks to expand ...

After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol ...

Bristol Myers Squibb, the pharmaceutical company headquartered in New Jersey, announced plans to lay off more than 500 ...

Bristol Myers Squibb, the pharmaceutical company headquartered in New Jersey, announced plans to lay off more than 500 ...